Trials / Completed
CompletedNCT05446493
Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction
Assessment of Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Aswan University · Academic / Other
- Sex
- Male
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The aim of this current study is to estimate serum level of YKL-40, serum total testosterone and platelets indices in diabetic patients with erectile dysfunction treated by daily tadalafil 5mg for 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tadalafil 5mg | * Estimate serum level of serum YKL-40, total testosterone and platelets indices in diabetic patients with erectile dysfunction treated by daily tadalafil 5mg for 3months. * Penile color Doppler ultrasound examination before and after treatment |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2021-03-15
- Completion
- 2022-01-05
- First posted
- 2022-07-06
- Last updated
- 2022-07-06
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05446493. Inclusion in this directory is not an endorsement.